BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7510042)

  • 1. Brief report: prenatal diagnosis of X-linked hyper-IgM syndrome.
    DiSanto JP; Markiewicz S; Gauchat JF; Bonnefoy JY; Fischer A; de Saint Basile G
    N Engl J Med; 1994 Apr; 330(14):969-73. PubMed ID: 7510042
    [No Abstract]   [Full Text] [Related]  

  • 2. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.
    Thomas C; de Saint Basile G; Le Deist F; Theophile D; Benkerrou M; Haddad E; Blanche S; Fischer A
    N Engl J Med; 1995 Aug; 333(7):426-9. PubMed ID: 7542361
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular genetic analysis of X-linked immunodeficiencies.
    Conley ME
    Year Immunol; 1993; 7():162-7. PubMed ID: 8372504
    [No Abstract]   [Full Text] [Related]  

  • 4. Localization of the genetic defect in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1) to the CD40 ligand gene.
    Fuleihan R; Ramesh N; Rosen FS; Geha RS
    Trans Assoc Am Physicians; 1993; 106():91-5. PubMed ID: 7518624
    [No Abstract]   [Full Text] [Related]  

  • 5. CD40 ligand and its role in X-linked hyper-IgM syndrome.
    Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
    Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
    Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
    Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
    Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
    Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
    DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
    Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of X-linked immunodeficiency with hyper-IgM and X-linked lymphoproliferative syndrome.
    Notarangelo LD; Mantuano E; Bione S; Gimbo E; Giliani S; Caraffini A; Purtilo D; Farr C; Ugazio AG; Toniolo D
    Immunodeficiency; 1993; 4(1-4):225-9. PubMed ID: 8167706
    [No Abstract]   [Full Text] [Related]  

  • 10. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
    Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
    J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
    Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
    J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency.
    Kutukculer N; Moratto D; Aydinok Y; Lougaris V; Aksoylar S; Plebani A; Genel F; Notarangelo LD
    J Pediatr; 2003 Feb; 142(2):194-6. PubMed ID: 12584544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1.
    Hollenbaugh D; Wu LH; Ochs HD; Nonoyama S; Grosmaire LS; Ledbetter JA; Noelle RJ; Hill H; Aruffo A
    J Clin Invest; 1994 Aug; 94(2):616-22. PubMed ID: 7518839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.
    Agematsu K; Nagumo H; Shinozaki K; Hokibara S; Yasui K; Terada K; Kawamura N; Toba T; Nonoyama S; Ochs HD; Komiyama A
    J Clin Invest; 1998 Aug; 102(4):853-60. PubMed ID: 9710455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
    Aruffo A; Farrington M; Hollenbaugh D; Li X; Milatovich A; Nonoyama S; Bajorath J; Grosmaire LS; Stenkamp R; Neubauer M
    Cell; 1993 Jan; 72(2):291-300. PubMed ID: 7678782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyper IgM syndrome: two mutations distinguish HIM.
    Foy TM; Masters SR; Noelle RJ
    J Clin Invest; 1994 Oct; 94(4):1349-50. PubMed ID: 7523448
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1).
    Ramesh N; Fuleihan R; Geha R
    Immunol Rev; 1994 Apr; 138():87-104. PubMed ID: 7520884
    [No Abstract]   [Full Text] [Related]  

  • 18. The biology of the human ligand for CD40.
    Spriggs MK; Fanslow WC; Armitage RJ; Belmont J
    J Clin Immunol; 1993 Nov; 13(6):373-80. PubMed ID: 7507124
    [No Abstract]   [Full Text] [Related]  

  • 19. X inactivation and immunocompetence in female carriers of the X-linked hyper-IgM syndrome.
    Kipps TJ
    J Clin Invest; 1994 Aug; 94(2):469. PubMed ID: 8040297
    [No Abstract]   [Full Text] [Related]  

  • 20. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.
    Lin Q; Rohrer J; Allen RC; Larché M; Greene JM; Shigeoka AO; Gatti RA; Derauf DC; Belmont JW; Conley ME
    J Clin Invest; 1996 Jan; 97(1):196-201. PubMed ID: 8550833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.